'Serum hbv dna level' presentation slideshows

Hepatitis Viruses

Hepatitis Viruses. A*. B**. C*. D*. E*. Viral Hepatitis overview. Source of. feces. blood/. blood/. blood/. feces. virus. blood-derived. blood-derived. blood-derived. body fluids. body fluids. body fluids. Route of. fecal-oral. percutaneous. percutaneous. percutaneous.

1.2k views • 102 slides

Hepatitis Viruses

Hepatitis Viruses. A*. B**. C*. D*. E*. Viral Hepatitis overview. Source of. feces. blood/. blood/. blood/. feces. virus. blood-derived. blood-derived. blood-derived. body fluids. body fluids. body fluids. Route of. fecal-oral. percutaneous. percutaneous. percutaneous.

1.49k views • 102 slides

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

461 views • 28 slides

GLOBE: Efficacy at Year 2, HBeAg-Positive Patients ITT Population

GLOBE: Efficacy at Year 2, HBeAg-Positive Patients ITT Population. *designates P <0.05, telbivudine vs lamivudine at Week 104. Adapted from AASLD 2006. GLOBE: Viral Load/Resistance at 24 Weeks. HBeAg Positive. HBeAg Negative. 100. 90. Telbivudine Lamivudine. 80. 70. 60. 56. 60. 50.

149 views • 2 slides